Navigating Hypopituitarism Diagnostics: Key Predictions for By 2023 to 2033


 The global Hypopituitarism Diagnostics Market is anticipated to reach a market value of US$ 250 million in 2023 and to reach US$ 447.41 million by 2033, at a CAGR of 6%. Between 2017 and 2022, the market for hypopituitarism diagnostics experienced a 4% CAGR.

The significant link between hypopituitarism and a lack of growth hormone is anticipated to drive market expansion. Human growth hormone aids in promoting growth, reproduction, and regeneration. Hormone deficiency is a severe problem for both children and adults, which is driving more and more study and development. For instance, in October 2019, Pfizer Inc. and its partner OPKO Health Inc. stated that the primary endpoint of their Phase III research testing Somatrogon's non-inferiority to daily somatropin in pre-pubertal children using human growth hormone had been met.

Request a report sample to gain comprehensive insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16373

Additionally, a number of start-ups are introducing new treatments for this uncommon illness. One such company is Eli, a Canadian FemTech start-up that is working on a saliva-based at-home gadget that can measure daily hormone variations and an app that offers insights specific to each user's individual profile. Despite being fundamental to women's reproductive and general health, hormones are still largely unknown. Eli opens this box, giving women access to their daily hormonal data. The company creates an at-home device that measures hormone variations in saliva as well as an app that provides women with the knowledge they need to take control of their daily and long-term health decisions.

Key Takeaways from the Market Study:

  • From 2018-2022, the hypopituitarism diagnostics market grew at a CAGR of 4%
  • The global hypopituitarism diagnostics market is expected to grow with a 6% CAGR during 2023-2033.
  • As of 2033, the Hypopituitarism Diagnostics Market is expected to reach US$ 447.41 Million
  • According to the FMI analysis, hospitals account for the largest market share
  • North America is expected to possess 25% market share for the Hypopituitarism Diagnostics market
  • Asia Pacific is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.

“Due to the hectic life patterns of the citizens working in cities, there has been an observed increase in stress and sleeplessness. These challenges are emerging as the main factor for the deteriorating health in the urban population by disrupting the hormonal balance in the human body,” says an FMI analyst.

Market Competition:

Key players in the Hypopituitarism Diagnostics market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Siemens AG, Hologic Inc., Qiagen NV, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific.

  • In January 2022, Pfizer Inc. and OPKO Health, Inc. announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients. Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward.

Key Segments Profiled in the Hypopituitarism Diagnostics Industry Survey

By Test Type:

  • Hormone Stimulation Tests
  • MRI or CT Scan
  • Visual Field Check
  • Insulin Tolerance Test

By End User:

  • Specialty Clinics
  • Hospitals
  • Academic Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Comments

Post a Comment

Popular posts from this blog

Beyond COVID-19: A Look at Vaccines Market Post-Pandemic From 2023 to 2033

Image
 In recent years, the Vaccines Market has undergone a dramatic transition brought on by ground-breaking scientific discoveries and the pressing need for universal immunisation. The COVID-19 pandemic acted as a stimulus for a surge in vaccine demand that has prompted academics and pharmaceutical corporations to develop at a previously unheard-of rate. This blog examines the changing market environment for vaccines, highlighting significant trends, difficulties, and opportunities. Technology advancements like mRNA and vector-based platforms have completely changed how vaccines are developed. These innovative techniques have proven to be remarkably effective against contagious illnesses like COVID-19, opening the door for the development of new vaccines. In response to the pandemic, mRNA vaccines were developed and distributed quickly, showcasing the promise of these ground-breaking technology. Supercharge Your Knowledge: Dive into the Booming Vaccines market with Our Sample Report @ ht
Read more

Key Players Shaping the 3D Cell Culture Market: By 2022 to 2031

Image
  The global 3D cell culture market is anticipated to account for a growth rate of around 9.8% over the forecast period from 2022 to 2031. The global market is expected to account for around US$ 1.15 Billion in 2022 and attain a valuation of US$ 2.67 Billion by 2031. According to the analysis done by Future Market Insights, the global 3D cell culture market accounted for a CAGR of 4.8% in 2021. During the historical period of 2016 to 2021, the 3D cell culture market expanded at a CAGR of 7.1%. According to the studies conducted by Future Market Insights, the comparative analysis along with the market growth rate of the global 3D cell culture market is expected to show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS, However, a positive BPS growth is expected in H1-2022 over H1- 2021 duration with 02 Basis Point Share (BPS). The global 3D cell culture market observes a drop in the BPS values owned to its disadvantage as compared to surface
Read more

Technological Advancements Fueling the Physiotherapy Equipment Market By 2023 to 2033

 The physical well-being and quality of life of people who are recuperating from injuries or who have chronic diseases are greatly enhanced by physical therapy. The Physiotherapy Equipment Market has experienced growth in tandem with the increase in demand for physiotherapy services. Due in large part to technological innovation, the prevalence of neurological and musculoskeletal illnesses is rising, and this sector of the economy is expanding quickly. The market for physiotherapy equipment has a large selection of gadgets and instruments made to help with the healing process. The industry has made considerable strides to meet a variety of treatment demands, from heat and cold therapy devices to electrotherapy machines and therapeutic exercise equipment. These contemporary resources help physiotherapists deliver more focused care, increase patient results, and enrich the therapeutic process as a whole. Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Physiotherapy E
Read more